The use of hematoporphyrin derivative (HpD) in the localization and treatment of transitional cell carcinoma (TCC) of the bladder.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002278:Carcinoma in Situ / Q000175:diagnosis / Q000188:drug therapy; D002295:Carcinoma, Transitional Cell / Q000175:diagnosis* / Q000188:drug therapy; D003558:Cystoscopy / Q000379:methods; D017324:Hematoporphyrin Derivative; D006415:Hematoporphyrins / Q000627:therapeutic use; D006801:Humans; D010778:Photochemotherapy / Q000379:methods*; D013050:Spectrometry, Fluorescence; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis* / Q000188:drug therapy
D000970:Antineoplastic Agents; D006415:Hematoporphyrins; D017324:Hematoporphyrin Derivative